Cary Street Partners Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Cary Street Partners Asset Management's MRK Position: Q3 2024 in Review
Cary Street Partners Asset Management increased its Merck (MRK) stake by 1.2% in Q3 2024, buying an estimated $87K and bringing the position to 60,855 shares worth $6.91M. The position accounts for 0.91% of the portfolio, ranked #27.
Cary Street Partners Asset Management first reported a position in MRK in Q4 2020 and has held it in 16 quarters since. The position peaked at $9.36M in Q4 2022. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.
- Cary Street Partners Asset Management held 60,855 shares of Merck worth $6.91M as of Q3 2024.
- Cary Street Partners Asset Management bought 732 Merck shares in Q3 2024, an estimated $87K.
- Merck made up 0.91% of Cary Street Partners Asset Management's portfolio in Q3 2024, its #27 holding.
- Cary Street Partners Asset Management first reported a position in Merck in Q4 2020 and has held it in 16 quarters since.
- Cary Street Partners Asset Management's Merck position peaked at $9.36M in Q4 2022.
- 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.
Based on Cary Street Partners Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.